Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Neeck

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
International Journal of Clinical Pharmacology Research|November 16, 2001
Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patientsL Färber, T H Stratz, W Brückle, et al.
Scandinavian Journal of Rheumatology. Supplement|October 12, 2000
The challenge of fibromyalgia: new approachesW Müller, D Pongratz, E Bärlin, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
International Journal of Clinical Pharmacology Research|November 16, 2001
Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patientsL Färber, T H Stratz, W Brückle, et al.
Scandinavian Journal of Rheumatology. Supplement|October 12, 2000
The challenge of fibromyalgia: new approachesW Müller, D Pongratz, E Bärlin, et al.
Pageof 5